Atindraa Pharmaceutical Private Limited

Atindraa Pharmaceutical Private Limited - pharma in Secunderabad, Telangana, India. Directors, charges & compliance details.
CIN U24230TG2022PTC161761 Incorporated 19 April 2022 ROC Hyderabad HQ Secunderabad, Telangana, India
Active Private Limited Company pharma
Revenue · FY 2023
₹1.63 Lakh
Latest filing
Net loss · FY 2023
₹1.22 Lakh
Net margin -74.7%
EBITDA · FY 2023
-₹1.22 Lakh
EBITDA margin -74.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2023
Balance sheet date

About Atindraa Pharmaceutical Private Limited

Data last updated:

Atindraa Pharmaceutical Private Limited is a private limited company based in Secunderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 April 2022.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2022PTC161761.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Raghuveer Paidi and Sujatha Perkit.

Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at H.No. 1 – 4 – 168/3/1 Tirumala Enclave Near Ion Digitel Old Alwal, Secunderabad, Telangana, India – 500010.

As per the financials filed for FY 2023, the company reported a revenue of ₹1.63 Lakh. For the same year it recorded a net loss of ₹1.22 Lakh (net margin -74.7%) and EBITDA of -₹1.22 Lakh (EBITDA margin -74.7%).

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24230TG2022PTC161761
Registration Number 161761
Incorporation Date 19 April 2022
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Atindraa Pharmaceutical Private Limited's registered office is in Secunderabad, Telangana.

  • Registered Address
    H.No. 1 – 4 – 168/3/1 Tirumala Enclave Near Ion Digitel Old Alwal, Secunderabad, Telangana, India – 500010
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Atindraa Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Atindraa Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Atindraa Pharmaceutical Private Limited, buy the company report.

Financials of Atindraa Pharmaceutical Private Limited

FY 2023 filings available

Atindraa Pharmaceutical Private Limited reported revenue of ₹1.63 Lakh for FY 2023.

Revenue · FY 2023
₹1.63 Lakh
Net loss · FY 2023
₹1.22 Lakh margin -74.7%
EBITDA · FY 2023
-₹1.22 Lakh margin -74.7%

Financial Statement Summary

MetricsFY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹1.22 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.22 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23
Profitability
EBITDA Margin-74.7%
Net Profit Margin-74.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Atindraa Pharmaceutical Private Limited, buy the company report.

Board of directors of Atindraa Pharmaceutical Private Limited

Atindraa Pharmaceutical has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Raghuveer PaidiDirector19 Apr 20224 Years 6 MonthsCurrent
Sujatha PerkitDirector19 Apr 20224 Years 6 MonthsCurrent

Peer comparison

Atindraa Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Cholas Pharmaceutical Private Limited₹1.66 Lakh (FY 2021)-14.0%Bisalpur, Uttar Pradesh, India
Anahat Minerals Private Limited₹1.65 Lakh (FY 2024)Surat, Gujarat, India
Atul Silicates Private Limited₹1.65 Lakh (FY 2024)12.0%Chennai, Tamil Nadu, India
Dr. Benade Herbal Private Limited₹1.64 Lakh (FY 2025)-61.0%Balewadi, Maharashtra, India
Jaxmon Pharma Private Limited₹1.64 Lakh (FY 2023)Nalasopara, Maharashtra, India
Atindraa Pharmaceutical Private Limitedthis company₹1.63 Lakh (FY 2023)-₹1.22 Lakh-74.7%Secunderabad, Telangana, India
RKJ Lubricant Oils Private Limited₹1.63 Lakh (FY 2024)-82.0%Valsad, Gujarat, India
Taruba Biologicals Private Limited₹1.63 Lakh (FY 2025)88.0%Kolkata, West Bengal, India
Yayy Naturals Private Limited₹1.63 Lakh (FY 2022)-8.0%Lucknow, Uttar Pradesh, India
Mihanika Refineries Private Limited₹1.63 Lakh (FY 2025)311.0%Hubli, Karnataka, India
Rgeno Pharmaceuticals Private Limited₹1.62 Lakh (FY 2024)-41.0%Navi Mumbai, Maharashtra, India

To see the full peer comparison of Atindraa Pharmaceutical Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Atindraa Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Atindraa Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Atindraa Pharmaceutical Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Raghuveer Paidi was appointed as Director on 19 Apr 2022.

AGM
Atindraa Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Atindraa Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Appointed
Raghuveer Paidi was appointed as Director.
Appointed
Sujatha Perkit was appointed as Director.
Incorporation
19 Apr 2022
Atindraa Pharmaceutical Private Limited was registered on 19 Apr 2022 with Roc Hyderabad & aged 4 years 6 months as per MCA records.

Frequently asked questions

Atindraa Pharmaceutical is an active private limited company based in Secunderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 April 2022 (4+ years old) and is registered under CIN U24230TG2022PTC161761.

Atindraa Pharmaceutical has 2 current directors:

The latest financial statements of Atindraa Pharmaceutical on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2023 are in the company report.

The CIN (Corporate Identification Number) of Atindraa Pharmaceutical is U24230TG2022PTC161761. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Atindraa Pharmaceutical was incorporated on 19 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Atindraa Pharmaceutical by revenue are Cholas Pharmaceutical Private Limited, Anahat Minerals Private Limited, Atul Silicates Private Limited, Dr. Benade Herbal Private Limited, Jaxmon Pharma Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Raghuveer Paidi was appointed as Director on 19 Apr 2022. Sujatha Perkit was appointed as Director on 19 Apr 2022.

The registered office of Atindraa Pharmaceutical is at H.No. 1 – 4 – 16831 Tirumala Enclave Near Ion Digitel Old Alwal, Secunderabad, Telangana, India – 500010.

Atindraa Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Atindraa Pharmaceutical is compliant as of 11 September 2026. The company is actively filing with the Registrar of Companies.

Atindraa Pharmaceutical can be reached at its registered office: H.No. 1 – 4 – 16831 Tirumala Enclave Near Ion Digitel Old Alwal, Secunderabad, Telangana, India – 500010.